Health-Chem Corporation Share Price

Equities

HCLC

US4221741022

Pharmaceuticals

Market Closed - OTC Markets 06:40:00 29/11/2023 am IST 5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Health-Chem Corporation -.--% -.--%
Sales 2005 7.59M 632M Sales 2006 5.94M 495M Capitalization 1.03M 85.85M
Net income 2005 -2M -167M Net income 2006 -1M -83.36M EV / Sales 2005 1.07 x
Net Debt 2005 7.49M 625M Net Debt 2006 7.14M 596M EV / Sales 2006 1.38 x
P/E ratio 2005
-0.36 x
P/E ratio 2006
-0.62 x
Employees -
Yield 2005 *
-
Yield 2006
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0.0001
0.00
3 years
0.00
Extreme 0.0001
0.04
5 years
0.00
Extreme 0.0001
0.07
10 years
0.00
Extreme 0
0.09
More quotes
Managers TitleAgeSince
President - -
Treasurer - -
Corporate Secretary - -
More insiders
Health-Chem Corporation conducts its business primarily through its 90%-owned subsidiary, Transderm Laboratories Corporation. Transderm owns 98.5% of Hercon Laboratories Corporation, which develops and manufactures controlled release products for the pharmaceutical industry, at Transderm's Pennsylvania facility, to deliver a variety of drugs topically or transdermally. The Company has manufactured over-the-counter pharmaceutical and cosmetic products that are used to clean facial pores. These deep cleansing facial pore strips are designed to remove clogged dirt, oil and blackheads from the nose, chin, forehead and anywhere else on the face that needs deep cleaning. In addition to its nitroglycerin transdermal products, the Company is also developing transdermal products for hormone replacement therapies.
More about the company